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SUMMARY 
The present study was conducted to investigate the long-term effects of chronic elevation of centrally 
circulating levels of corticotropin-releasing factor (CRF) on behavior and physiology. For this 
purpose ovine CRF was infused continuously for a period of 10 days into the lateral ventricle of rats 
with the aid of osmotic pumps (calculated CRF delivery was 4.9/~g/day). Changes in daily rhythms in 
body temperature and home cage motor activity were recorded telemetrically during the infusion 
period. The most prominent physiological findings were a delayed body weight gain and a long- 
lasting hyperthermia following CRF infusion. The peptide treatment furthermore increased adrenal 
weight and suppressed the weight of the thymus at the end of the experiment. Behaviorally, CRF 
administration elicited a short-lasting increase in activity during the light phase and an increased 
anxiety in an elevated plus-maze 1 week after the start of infusion. The similarities between the 
present results and the long-term changes previously described in behaviorally stressed rats indicate 
that chronically elevated levels of CRF in the brain might play an important role in the induction and 
persistence of stress-related behavioral and physiological disorders. © 1997 Elsevier Science Ltd 
Keywords--CRF or CRH; Brain; Stress; Telemetry; Body temperature; Activity; Daily rhythm. 
INTRODUCTION 
Corticotropin-releasing factor (CRF) is intimately involved in the expression of autonomic, 
endocrine and behavioral responses to stress. The peptide functions both as a neurohormone 
in the hypothalamic-pituitary axis to elicit adrenocorticotropin (ACTH) secretion (Vale et 
al., 1981) and as a neurotransmitter in various extrahypothalamic regions to initiate 
autonomic and behavioral components of the stress response (Sawchenko et al., 1993). 
When injected centrally into the cerebrospinal fluid of experimental animals, CRF produces 
stress-related behavioral changes which depend on the state of arousal of the animal (Koob 
et al., 1993; Korte et al., 1992; Takahashi et al., 1989). CRF further acts in several areas of 
the brain as a transmitter enhancing sympathetic nervous and adrenomedullary activity 
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(Fisher, 1989). By a concurrent inhibition of vagal nerve activity (Fisher, 1989; Wiersma et 
al., 1993) CRF causes a shift in balance towards the sympathetic division of the autonomic 
nervous ystem. 
The majority of the studies mentioned above describe acute responses to intracerebro- 
ventricular (ICV) CRF administration. Based on the similarities between many of these 
short-lasting effects of centrally administered CRF and the behavioral signs and 
physiological symptoms that occur in human affective disorders, an important role for 
CRF in the pathophysiology of affective disorders was suggested (Nemeroff et al., 1984). 
Several clinical studies have found direct and indirect evidence supporting the hypothesis 
that CRF is hypersecreted from one or more populations of neurons in the brain of patients 
diagnosed for major depressive disorder. Nemeroff et al. (1984) demonstrated increased 
concentrations of CRF in the cerebrospinal fluid of these patients. In addition, there are 
reports of a blunted ACTH response to intravenously administered CRF in depressed 
patients (Holsboer et al., 1984). It is hypothesized that this hyporesponsivity is caused by a 
downregulation i CRF binding sites following CRF hypersecretion i  major depression 
(Owens and Nemeroff, 1993). Several animal studies focussed on the behavioral, 
physiological and anatomical consequences of the chronic elevation of centrally circulating 
CRF by infusing CRF into the brain, mimicking the hypothesized CRF hypersecretion i  
depressed patients. Hauger et al. (1993) showed that chronic ICV CRF infusion induced a 
downregulation of CRF receptors in the amygdala but not in the anterior pituitary. Body 
weight and food intake were clearly reduced (Arase et al., 1988); thermogenesis in brown 
adipose tissue was increased (LeFeuvre et al., 1987) as was hypothalamic-pituitary- 
adrenocortical xis activity (Cunningham et al., 1988; Labeur et al., 1995; Miyanaga et al., 
1990). Behavior in a variety of tests was affected (Song et al., 1995), and parts of the 
immune system were suppressed (Hauger et al., 1993; Labeur et al., 1995). Many of these 
CRF-induced changes are similar to features of major depressive disorder (DSM-III-R, 
1987). There are no experimental nimal or clinical studies that present continuous long- 
term recordings of behavioral and physiological data during chronic CRF administration i to 
the brain. 
Considering both the crucial role of CRF in the stress response as well as the alterations in 
central CRF systems in depression, it is important o realize that stressful life events are 
considered to play an important role in the etiology of human depressive disorders (Anisman 
and Zacharko, 1982). This causal relationship between stress and depresssion has led to the 
development of animal models for psychological disorders. The long-term behavioral effects 
of psychosocial stressors uch as social defeat in rats suggest he development of a long- 
lasting state of depression in defeated animals (Koolhaas et al., 1990). The fact that the 
physiological and behavioral alterations following psychosocial stress can be counteracted 
by the application of antidepressants and sleep deprivation further strengthens the idea that 
these animal models might be valuable tools in the study of the mechanisms involved in the 
pathogenesis of depressive disorders (Fuchs et al., 1996; Koolhaas et al., 1990; Meerlo et al., 
1996b). Telemetric studies showed that daily rhythms of body temperature, heart rate and 
motor activity are affected for several days in defeated rats (Kant et al., 1991; Meerlo et al., 
1996a, 1996b; Tornatzky and Miczek, 1993). Because acute and chronic behavioral stressors 
are reported to increase the biosynthesis and release of CRF in various brain regions 
(Chappell et al., 1986; Imaki et al., 1991) and affect the number and sensitivity (Fuchs and 
Fl/igge, 1995; Sapolsky, 1989) of CRF binding sites in the brain and pituitary, high 
concentrations of central CRF might be hypothesized to play an important role in the 
Corticotropin-releasing Factor in the Rat 2q9 
induction and persistence of the altered physiology and behavior of the defeated animals. 
This hypothesis i strengthened by the finding that a CRF antagonist administered 1CV 
reduces emotionality in socially defeated rats (Heinrichs et al., 1992). 
To test further the hypothesis that chronically enhanced levels of CRF may explain the 
behavioral and physiological changes observed in behaviorally stressed rats, the present 
study was conducted to investigate the long-term effects of chronic elevation of centrally 
circulating levels of CRF on behavior and physiology. For this purpose CRF was infused 
into the lateral ventricle of rats with the aid of osmotic minipumps, in order to obtain a 
sustained increased concentration f CRF in the central nervous ystem. Subsequent changes 
in daily rhythms in body temperature and motor activity were recorded telemetrically for a 
period of 10 days, in order to compare the effects of CRF administration with the previously 
described long-term behavioral and physiological effects of social defeat. Effects of CRF 




Male Wistar rats, weighing 320-390 g at the start of the experiments, were housed 
individually in clear Plexiglas cages (25 x 25 x 30 cm) on a layer of wood shavings in a 
room with constant temperature (21 ± 2~C) and fixed, reversed 12 h light-dark regime (light 
on at 2000h). The animals had free access to standard rat chow and tap water. 
Surgery and Data Acquisition 
Body temperature and gross locomotor activity were recorded prior to and throughout the 
entire 10-day infusion period by means of radiotelemetry. For this purpose a transmitter 
(model TA10TA-F40, Data Sciences, St Paul, MN) was implanted intraperitoneally under 
ether anesthesia. The transmitters produced a temperature-dependent fr quency-modulated 
signal, which was received with an antenna board (model RA1010, Data Sciences) 
underneath e cage. Locomotor activity was obtained by monitoring changes in the received 
signal strength that resulted from movement of the animal. Changes in signal strength 
beyond a predetermined threshold generated a pulse that was counted by the acquisition 
system. It is important to note that for detection of activity the transmitter had to move. 
Therefore, with the transmitter implanted in the peritoneal cavity, slight head movements 
during grooming or eating were not registered as activity. Data were collected and processed 
by a computer with a specialized recording and analysis system (Dataquest IV, Data 
Sciences). Body temperature was sampled for 10 s every 10 min. Locomotor activity was 
recorded continuously and stored at 10-rain intervals. One hour averages were calculated 
and are presented in this paper. 
Together with the implantation of the transmitter, a stainless teel cannula (Alzet brain 
infusion cannula, Alza Corp., Palo Alto, CA) was stereotaxically placed into the right lateral 
ventricle. The cannula was connected with a subcutaneous polyvinylchloride catheter tube 
which was sealed at one end. Tubing and cannula were filled with a standard amount of 
sterile saline (calculated for _+ 18 h pumping) in order to avoid CRF delivery immediately 
following the implantation of osmotic minipumps. 
After 3 weeks of recovery the catheters were attached to osmotic minipumps (Alzet, 
model 2002, having a constant pumping rate of 0.5/~l/h for 14 days) which were inserted 
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Fig. 1. Changes in body weight following ICV infusion of CRF or vehicle. *p < .05; significant 
difference between CRF- and vehicle-treated groups, one-way ANOVA. 
subcutaneously at the level of the scapulae. The placement of these pumps was performed 
under brief (less than 5 min) ether anesthesia. The pumps contained either vehicle (saline 
with 0.1% bovine serum albumin (BSA) and 0.01% ascorbic acid) or ovine CRF dissolved in 
the vehicle solution. The experiments were performed in two cohorts of animals, each cohort 
receiving CRF from a different distributor (Sigma, St Louis, MO and American Peptide Co., 
Sunnyvale, CA). The behavioral and physiological findings were similar in both CRF-treated 
groups. The calculated CRF delivery was 4.9 #g/day. 
Ten days after the start of infusion the rats were killed. On this day adrenals and thymus 
were removed and weighed. 
Behavior in the Elevated Plus-maze 
On the seventh day after the start of either CRF or vehicle infusion the rats were exposed 
to the elevated plus-maze in order to study the effect of chronic CRF infusion on levels of 
anxiety. The procedure of the test has been described in detail by Pellow et al. (1985). In 
short, the apparatus was a black wooden, plus-shaped maze, elevated to a height of 50 cm. 
Two opposite arms were open (50 × 10 cm), whereas the other two were enclosed with 
walls (50 × 10 × 40 cm). Rats were placed individually in the center of the maze with their 
head inside one of the closed arms. The number of entries into open and closed arms and the 
time spent on open and closed arms was scored during 5 min exposure to the maze. In 
addition, the percentage time spent on the open arms (open time/(open time + closed time) 
× 100) and percentage ntries into open arms (entries open/total entries × 100) were 
calculated. The light intensity on the open arms varied, ranging from 10 lux close to the 
center of the maze to 80 lux on the end of the open arms. In the closed arms it was less than 
1 lux. 
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Statistical Analysis 
Body temperature and home cage activity were averaged over 12 h light and dark phases. 
The amplitude of the rhythm was defined as the difference between an average dark value 
and the subsequent average light value. Statistical analysis was performed on mean light and 
dark values and amplitude values. To assess the overall effects of vehicle and CRF infusion 
on body temperature and activity, groups were compared with analyses of variance 
(ANOVAs) for repeated measures over the 10-day period following the start of CRF 
infusion. For post hoc analysis the Dunnett's test was used to determine significance 
between pairs of means. Within-group changes were analysed with a paired t-test. Effects of 
CRF administration on body and organ weight and on behavior in the elevated plus-maze 




At the start of infusion the mean body weight of the group of animals receiving vehicle 
solution was higher than that of CRF-treated animals (403.9 _+ 9.8 vs. 357.1 _+ 6.8). For this 
reason changes in body weight following infusion were expressed as percentage change 
relative to the weight at the start of the treatment. The vehicle-administered controls 
gradually gained weight, whereas CRF caused an initial loss of weight during the first 2 days 
alter start of the infusion (see Fig. 1 ) (p < .05), after which the rats regained weight but 
failed to catch up with the controls. There was a significant treatment effect 
IF(l,8)= 189,70, p<.001] and an interaction between treatment and time 
[/'(8,64) = 17.16, p < .001]. 
Body Temperature and Activity 
The hourly registrations of temperature and activity (Fig. 2) and the calculated amplitudes 
between light and dark periods (Fig. 4) show that implantation and connection of the osmotic 
minipump (indicated by arrows in Fig. 2 and Fig. 4) reduced temperature amplitude on the 
day following implantation (p < .05). In vehicle-infused rats this reduction was transient and 
lasted only 24 h, whereas for the rest of the infusion period temperature amplitudes were 
similar to baseline values, indicating that ICV infusion of the saline vehicle did not affect 
temperature gulation. The implantation procedure and infusion of saline did not disturb the 
stable course of home cage motor activity during light and dark periods, as indicated by the 
results in controls. CRF infusion, however, caused a long-lasting increase in body 
temperature during both the light and the dark phase. Effects on motor activity were less 
pronounced, although an initial decrease in the circadian amplitude (Fig. 4) occurred ue to 
increased activity during the light phase. Comparison of the mean values of body 
temperature and activity during the light and the dark phase (Fig. 3) revealed a significant 
effect of CRF treatment on body temperature following implantation of the osmotic pump 
[F(1,18) = 74.57, p < .001]. There was also a significant interaction between treatment and 
time [F(23,414) = 5.99, p < .001]. Post hoc analysis howed that the body temperature was 
significantly higher in CRF-treated animals compared to controls during the whole period 
following the start of infusion except for the first night (dark phase of day 0) and at the end 
the infusion period (dark phase of day 7 and light phase of day 8). Five days after start of 
infusion the night temperature was not significantly increased compared to baseline levels 2 
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Fig. 2, The effect of chronic ICV infusion of CRF by means of SC osmotic minipumps on daily 
rhythms of body temperature and home cage activity compared to vehicle infusion. Pumps were 
implanted and connected to ICV cannulas +_18 h (indicated by arrow on X-axis) before the start of 
actual CRF infusion into the brain. This effective peptide infusion period is shaded in the figure. The 
temperature and activity data represent hourly averaged values. 
days before start of infusion. Light phase temperature was back to baseline on the last day. 
These findings indicate that the effect of CRF administration on body temperature habituates 
during the infusion period. No overall effect of CRF was measured on motor activity, 
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Fig. 3. Mean 12 h light and dark phase values of body temperature and home cage activity before and 
during ICV infusion of CRF or vehicle. Dark phase is indicated by shaded columns. 
indicated by a non-significant treatment effect. Measurement of the daily amplitudes 
between night and day values (Fig. 4) showed a significant interaction between treatment 
and time for both the body temperature and motor activity [F(12,216) = 2.54, p = .004 and 
F(12,216) = 2.01, p = .02, respectively]. Post hoc analysis indicated a decreased amplitude 
of daily temperature (/9 < .05) in CRF-treated rats on days 0, 1, 3, 5, 6 and 7. The amplitude 
of activity was significantly lower than in vehicle-treated rats on day 0 only. 
Behavior in the Elevated Plus-maze 
When tested 7 days after the infusions started, CRF-treated rats spent significantly less 
time on the open arms of the plus-maze (IF(I,19)= 7.36, p = .01] and also made fewer 
entries into open arms [F(1,19)=7.11, p= .02] (Fig. 5). The total number of entries was 
similar in controls and CRF-treated rats (13 _ 1 and 14 __. 1, respectively). 
Organ Weights 
Table I shows that ICV CRF infusion caused a significant increase in adrenal organ weight 
(p < .01) and decreased the weight of the thymus (p < .05). 
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Fig. 4. Circadian amplitudes of daily rhythms of temperature and activity. Amplitudes were calculated 
as the difference between an average dark value and the subsequent light value. The arrow indicates 
the moment of pump implantation under brief ether anesthesia. 
DISCUSSION 
The present report is the first that shows the effects of chronic ICV CRF infusion on the 
daily rhythms of body temperature and home cage activity by means of telemetry. The most 
prominent physiological findings were a delayed body weight gain and a long-lasting 
hyperthermia following CRF infusion. The chronic peptide treatment increased adrenal 
weight and suppressed the weight of the thymus. Behaviorally, CRF administration elicited a 
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Fig. 5. Behavior on an elevated plus-maze 7 days after the start of ICV CRF or vehicle infusion. 
Percentage time spent on open arms and percentage of open entries is presented. *p < .(15: significanl 
difference between CRF- and vehicle-treated groups, one-way ANOVA. 
short-lasting increase in activity during the light phase and an increased anxiety in an 
elevated plus-maze 1 week after the start of infusion. Although we expect he effects of this 
relatively low concentration of CRF to be mediated through the central nervous actions of 
CRF, a peripheral contribution to the effects can not be excluded completely since Martins ct 
al. (1996) showed a rapid CRF transport out of the brain. 
The reduced gain in body weight after chronic CRF administration is in line with other 
studies (Arase et al., 1988; Labeur et al., 1995), and closely resembles the delay in body 
weight gain observed in rats subjected to social defeat (Meerlo et al., 1996c). It is also 
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Table I. Adrenal and thymus weight of vehicle- and CRF-administered rats 
Adrenal (rag/100 gbw) Thymus (rag/100 gbw) 
Control 6.95 ± 0.41 112.16 +_ 9.92 
CRF 9.75 _+ 0.57** 74.49 _+ 8.3* 
*p < .05, indicates ignificant difference from control-treated rats, one-way ANOVA. 
**p < .01. 
similar to observations in depressed patients (DSM-III-R, 1987). Both the effects of CRF 
and of psychosocial stress on body weight seem to be attributed in part, but not completely, 
to the inhibition of food intake. The recently described potent reduction of appetite by CRF2 
receptors might be an indication of how CRF can be responsible for the effects on food 
intake (Spina et al., 1996) and body weight. A change in metabolism is also likely to 
contribute to the reduced growth (Arase et al., 1988; Meerlo et al., 1996c). In the case of 
CRF administration, the sympathetic activation (Fisher, 1989) together with glucocorticoid- 
evoked catabolic effects, as indicated by the increased adrenal weight at the end of the 
infusion period, play an important role in the metabolic change. Increased levels of 
circulating lucocorticoids following chronic ICV CRF infusion (Arase et al., 1988; Labeur 
et al., 1995) may also be largely responsible for the reduced thymus weight in the peptide- 
treated animals. 
The long-lasting hyperthermia during both day and night-time following chronic CRF 
infusion has not been described before. This increase in body temperature gradually 
habituates during the infusion period, indicating a decreasing efficacy in time of the infused 
peptide to influence this physiological parameter. This habituation is possibly due to a 
downregulation of CRF receptors and not to a decreased physiological potency of the 
peptide in the osmotic pumps after 10 days, as indicated by the study of Hauger et al. (1993). 
A number of studies show the involvement of central CRF in temperature gulation. An 
acute short-lasting hyperthermia follows ICV injection of CRF and a stress-induced 
hyperthermic response is attenuated by administration of the CRF receptor antagonist ~- 
helical CRF (Morimoto et al., 1993). Given the well-known stimulating effect of CRF within 
the brain on sympathetic outflow, it was hypothesized that sympathetically induced non- 
shivering thermogenesis by the activation of brown adipose tissue (Hardwick et al., 1989; 
Holt and York, 1989; LeFeuvre et al., 1987) might play an important role in the 
hyperthermia following CRF injection. Whether this is also the case for the long-term 
hyperthermia in the present study is not known. The central actions of CRF on acute 
thermogenesis might be mediated in part by the pro-opiomelanocortin products ~I-MSH and 
/¢-endorphin (Rothweil et al., 1991). Finally the blockade of the pyrogenic actions of 
interleukin-lfl by ICV administration of 7-helical CRF (Rothwell, 1989) further indicates 
the important role of central CRF systems in temperature gulation. 
Comparison of the temperature data with clinical studies indicate a similarity with drug- 
free patients with endogenous depression who had significantly higher temperature minima 
than did normol controls, also resulting in a reduction of the amplitude of daily temperature 
rhythm (Beersma et al., 1983; Daimon et al., 1992). The time course of the temperature 
response during chronic CRF infusion, as observed in the present study, furthermore at first 
sight shows a striking similarity to that of the temperature sponse following social defeat 
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(Meerlo et al., 1996a). The reduction in temperature amplitude after social stress, however, 
was caused by an increased temperature stricted mainly to the light phase, whereas the 
CRF infusion also increased body temperature during the dark phase. A likely explanation is
that the high concentration of administered CRF by osmotic minipumps in the present 
experiments i  able to increase the already elevated night body temperature further, whereas 
social stress is less severe in this respect. Another interesting hypothesis might be that social 
stress increases CRF secretion mainly during daytime, and in this way interferes with the 
existing diurnal variation in CRF concentration that exists in various brain regions (Owens et 
al., 1990). The constantly elevated levels of centrally circulating CRF in our study possibly 
interfere with these diurnal fluctuations in regional CRF concentration. 
The short-lasting increase of ICV CRF infusion on motor activity during the light phase in 
the home cage is in line with reports on the acute effects of CRF on behavioral activity in a 
familiar environment (Koob and Bloom, 1985; Korte et al., 1992). Compared with the long- 
lasting increase of body temperature, the short-lasting effect of chronic CRF infusion on 
motor activity is somewhat surprising. A possible methodological explanation is that the 
biotelemetric way of measuring locomotor activity is not sensitive enough to produce 
striking differences in relatively small individual home cages. Because only the amount of 
horizontal movements is measured, changes in other types of motor activity such as 
grooming or rearing are poorly monitored. However, it is also possible that tolerance to 
chronic CRF infusion is actually differential in time for motor activity in a familiar 
environment and physiology due to different central mechanisms involved. 
An increased anxiety after 1 week of central CRF infusion is demonstrated by the 
decrease in time spent on and fewer entries into the open arms of an elevated plus-maze. A
similar acute effect of CRF on behavior in this model of anxiety has been published before 
(Adamec et al., 1991). The stress of social defeat also results in a long-term increase in 
emotionality in various behavioral test situations (Koolhaas et al., 1990; Meerlo et al., 
1996a, 1996b). 
The results in this study show that there are many similarities between the long-term 
behavioral and physiological consequences of chronic ICV CRF infusion and a single 
behavioral stressor such as social defeat, giving support o the hypothesis that chronically 
elevated levels of centrally circulating CRF might play an important role in the induction 
and persistence of the depressed behavioral and physiological state following psychosocial 
,;tress. 
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